Diabetes mellitus doubles the risk of type 2 cardiorenal syndrome: results from the NHANES trial
Main Authors: | Nikolaos Tentolouris, Ioanna Eleftheriadou |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2017-09-01
|
Series: | Hellenic Journal of Cardiology |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1109966617305936 |
Similar Items
-
Clinical Management of Diabetes Mellitus in the Era of COVID-19: Practical Issues, Peculiarities and Concerns
by: Chrysi Koliaki, et al.
Published: (2020-07-01) -
Pulse wave velocity and cardiac autonomic function in type 2 diabetes mellitus
by: Stamatina Chorepsima, et al.
Published: (2017-05-01) -
Cardiorenal syndrome in patients with chronic kidney disease and diabetes mellitus
by: Irina Mikhailovna Kutyrina, et al.
Published: (2013-11-01) -
Low-Glycemic-Index/Load Desserts Decrease Glycemic and Insulinemic Response in Patients with Type 2 Diabetes Mellitus
by: Vasiliki Argiana, et al.
Published: (2020-07-01) -
Management of Cardiorenal Metabolic Syndrome in Diabetes Mellitus: A Phytotherapeutic Perspective
by: Min Kyong Song, et al.
Published: (2014-01-01)